Randomized controlled trials on hepato-biliary-pancreatic surgery

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 11, Issue 6, 2004, Pages 381-389

  Kaido, Toshimi ^a  

^a OTSU MUNICIPAL HOSPITAL   (Japan)

Author keywords

Biliary tract cancer; Evidence based medicine; Hepatocellular carcinoma; Pancreas cancer; RCT

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; DOXORUBICIN; FLUOROURACIL; INTERFERON; IODINATED POPPYSEED OIL; IODINE 131; MITOMYCIN C; POLYPRENOIC ACID; RETINOID;

ARTIFICIAL EMBOLISM; BILE DUCT CANCER; BILIARY TRACT SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL STUDY; CLINICAL TRIAL; CONSENSUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FREQUENCY ANALYSIS; HUMAN; LIVER CANCER; LIVER SURGERY; MALIGNANT NEOPLASTIC DISEASE; PANCREAS CANCER; PANCREAS SURGERY; REVIEW; STANDARD; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BILIARY TRACT NEOPLASMS; BILIARY TRACT SURGICAL PROCEDURES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 11244300946     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-004-0927-2     Document Type: Review

References (68)

1. Evidence-Based Medicine Working Group (1992) Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 268:2420-2425
2. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence-based medicine: What it is and what it isn't. BMJ 312:71-72
3. Horton R (1996) Surgical research or comic opera; questions, but few answers. Lancet 347:984-985
4. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J (1997) Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 226:704-711
5. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O (1999) Continuous versus intermittent protal triad clamping for liver resection: A controlled study. Ann Surg 229:369-375
6. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A (1996) Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 224:155-161
7. Clavien PA, Selzner M, Rudiger HA, Graf R, Hadry Z, Rousson V, Jochum W (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 238:843-850
8. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, Ijichi M, Hasegawa K (2001) Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 136:922-928
9. Belghiti J, Kabbej M, Sauvanet A, Vilgrain V, Panis Y, Fekete F (1993) Drainage after elective hepatic resection. A randomized trial. Ann Surg 218:748-753
10. Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194-201
11. Ijichi M, Takayama T, Toyoda H, Sano K, Kubota K, Makuuchi M (2000) Randomized trial of the usefulness of a bile leakage test during hepatic resection. Arch Surg 135:1395-1400
12. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Sugimachi K (2001) Effects of preoperative steroid administration on surgical stress in hepatic resection: Prospective randomized trial. Arch Surg 136:328-333
13. Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L (2003) Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 90:17-22
14. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32:1224-1229
15. Yamasaki S, Haseagawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R, Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu T, Ikeda K, Yamamoto M, Saoshiro T, Tsuzuki T (1996) A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87:206-21116.
16. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334:1561-1567
17. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32:228-232
18. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, Shiomi S, Tamori A, Oka H, Igawa S, Kuroki T, Kinoshita H (2001) Effects of long-term postoperative interferonalpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 134:963-967
19. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. Lancet 353:797-801
20. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kazkizoe T (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial. Lancet 356:802-807
21. Kroger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H, Geissler M (2001) Growth suppression of the hepatocullar carcinoma cell line Hepal-6 by an activatable interferon regulatory factor-1 in mice. Cancer Res 61:2609-2617
22. Yano H, Iemura A, Haramaki M, Ogasawara S, Takayama A, Akiba J, Kojiro M (1999) Interferon alfa receptor expression and growth inhibition by inerferon alfa in human liver cancer cell lines. Hepatology 29:1708-1717
23. Murphy D, Detjen KM, Welzel M, Wiedenmann B, Rosewicz S (2001) Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclindependent kinases. Hepatology 33:346-356
24. Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M (2002) Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94:435-442
25. Ohmoto K, Iguchi Y, Mimura N, Tsuduki M, Shimabara M, Kuboki M, Yamamoto S (2003) Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma. Hepatogastroenterology 50:1780-1782
26. Kaido T, Arii S, Shimada Y, Mori A, Imamura M (2003) Portal embolization in various types of liver: Novel variables to predict hypertrophy. Hepatogastroenterology 50:140-145
27. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN (2003) Preoperative portal vein emboalization for extended hepatectomy. Ann Surg 237:686-691
28. Takayama T, Makuuchi M (2004) Preoperative portal vein embolization: Is it useful? J Hepatobiliary Pancreat Surg 11:17-20
29. Belghiti J (2004) Arguments for a selective approach of portal vein embolization before major hepatic resection. J Hepatobiliary Pancreat Surg 11:21-24
30. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355-366
31. Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA, Coleman J, Sauter PK, Abrams RA, Hurban RH, Yeo CJ (2003) Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: A prospective, randomized trial evaluaing quality of life in pancreaticoduodenectomy survivors. J Gastrointest S-rg 7:1-9
32. Takada T (2001) Is preoperative biliary drainage necessary according to evidence-baseds medicine? J Hepatobiliary Pancreat Surg 8:58-64
33. Smith RC, Pooley M, George CR, Faithful GR (1985) Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: A randomized, controlled trial examining renal function. Surgery 97:641-648
34. Wig JD, Kumar H, Suri S, Gupta NM (1999) Usefulness of percutaneous transhepatic biliary drainage in patients with surgical jaundice - a prospective randomised study. J Assoc Physicians India 47:271-274
35. Hatfield AR, Tobias R, Terblanche J, Girdwood AH, Fataar S, Harries-Jones R, Kernoff L, Marks IN (1982) Properative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet II:896-899
36. McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB, Allison DJ, Blumgart LH (1984) Pre-operative percutaneous transhepatic biliary drainage: The results of a controlled trial. Br J Surg 71:371-375
37. Lai EC, Mok FP, Fan ST, Lo CM, Chu KM, Liu CL, wong J (1994) Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81:1195-1198
38. Tringali A, Mutignani M, Perri V, Zuccala G, Cipolletta L, Bianco MA, Rotondano G, Philipper M, Schumacher B, Neuhaus H, Schmit A, Deviere J, Costamagna G (2003) A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy 35:992-997
39. Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, Canard JM, Fritsch J, Rey JF, Burtin P (2003) Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57:178-182
40. Wagner HJ, Knyrim K, Vakil N, Klose KJ (1993) Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 25:213-218
41. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K (1992) Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488-1492
42. Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, MacRae KD, Houghton J, Lennon CA (1987) Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet II:57-62
43. Van Heek NT, De Castro SM, van Eijck CH, van Geenen RC, Hesselink EJ, Breslau PJ, Tran TC, Kazemier G, Visser MR, Busch OR, Obertop H, Gouma DJ (2003) The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238:894-902
44. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J, Pitt HA, Yeo CJ (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230:322-328
45. Shyr YM, Su CH, King KL, Wang HC, Lo SS, Wu CW, Lui WY (1997) Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer. Surgery 121:506-512
46. Takada T, Nimura Y, Katoh H, Nagakawa T, Nakayama T, Matsushiro T, Amano H, Wada K (1998) Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for nonresectable pancreatic and biliary carcinoma: Multicenter randomized trial. Hepatogastroenterology 45:2020-2026
47. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T; Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695
48. Nimura Y (2002) Extended surgery in bilio-pancreatic cancer: The Japanese experience. Semin Oncol 29:17-22
49. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: Audit of 52 consecutive cases. Ann Surg 238:720-727
50. Kaido T, Imamura M. Unresectable hilar cholangiocarcinoma completely reduced by external radiation therapy. Hepatogastroenterology (in press)
51. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Kloppel G, Dhaene K, Michelassi F (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508-517
52. Imamura M, Doi R (2004) Treatment of locally advanced pancreatic cancer: Should we resect when resectable? Pancreas 28:293-295
53. Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW (2000) Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): Initial clinical results. J Gastrointest Surg 4:443-452
54. Lin PW, Lin YJ (1999) Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86:603-607
55. Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, Lillemoe KD, Pitt HA (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222:580-588
56. Suzuki Y, Fujino Y, Tanioka Y, Hori Y, Ueda T, Takeyama Y, Tominaga M, Ku Y, Yamamoto YM, Kuroda Y (1999) Randomized clinical trial of ultrasonic dissector of conventional division in distal pancreatectomy for non-fibrotic pancreas. Br J Surg 86:608-611
57. Suzuk Y, Kuroda Y, Morita A, Fujino Y, Tanioka Y, Kawamura T, Saitoh Y (1995) Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Arch Surg 130:952-955
58. Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmieres F, Sastre B, Fagniez PL; and the French Associations for Surgical Research (2003) Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abbdominal complications after pancreatic resection: Prospective randomized trial. Ann Surg 237:57-65
59. Conlon KC, Labow D, Leung D, Smith A, Jarnagin W, Coit DG, Merchant N, Brennan MF (2001) Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 234:487-493
60. Izbicki JR, Bloechle C, Knoefel WT, Kuechler T, Binmoeller KF, Broelsch CE (1995) Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis. A prospective, randomized trial. Ann Surg 221:350-358
61. Buchler MW, Friess H, Muller MW, Wheatley AM, Beger HG (1995) Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 169:65-69
62. Sarr MG; Pancreatic Surgery Group (2003) The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: A prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196:556-564
63. Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163:125-130
64. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW; European Study Group for Pancreatic Cancer (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial. Lancet 358:1576-1585
65. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randominzed trial. J Clin Oncol 15: 2403-2413
66. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637-639
67. Moher D, Schulz KF, Altman D; CONSORT Group (2001) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285:1987-1991
68. Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887-1892